Bill

Bill > S2392


NJ S2392

NJ S2392
Authorizes medical cannabis for treatment of sickle cell anemia.


summary

Introduced
01/29/2024
In Committee
12/15/2025
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill expands the list of medical conditions that qualify a patient for the medical use of cannabis to include sickle cell anemia. Sickle cell anemia is an inherited blood disorder characterized primarily by chronic anemia and periodic episodes of pain. The medical use of cannabis can treat or alleviate the pain or other symptoms associated with certain medical conditions.

AI Summary

This bill expands the list of qualifying medical conditions for the medical use of cannabis by adding sickle cell anemia, an inherited blood disorder that causes chronic anemia and painful episodes. This change allows individuals diagnosed with sickle cell anemia to potentially receive medical cannabis to manage their symptoms, as the medical use of cannabis is recognized as a treatment for pain and other symptoms associated with certain medical conditions.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (3)

Last Action

Substituted by A913 (on 12/22/2025)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://www.njleg.state.nj.us/bill-search/2024/S2392
BillText https://pub.njleg.gov/Bills/2026/S2500/2392_I1.HTM
Fiscal Note - Fiscal Estimate 12/18/25; CC https://pub.njleg.gov/Bills/2024/S2500/2392_E2.PDF
Analysis - Statement SBA 12/15/25 https://pub.njleg.gov/Bills/2024/S2500/2392_S2.PDF
Fiscal Note - Fiscal Estimate 11/24/25; as introduced https://pub.njleg.gov/Bills/2024/S2500/2392_E1.PDF
Analysis - Statement SHH 11/13/25 https://pub.njleg.gov/Bills/2024/S2500/2392_S1.PDF
BillText https://pub.njleg.gov/Bills/2024/S2500/2392_I1.HTM
Loading...